Mechlorethamine

CHEMBL427 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
156.0 g/mol
LogP
0.9
Phase
4

A nitrogen mustard alkylating agent used as a chemotherapy treatment for certain blood cancers including Hodgkin lymphoma and mycosis fungoides, working by cross-linking DNA strands to prevent cancer cell replication. It is one of the oldest chemotherapy drugs still in use today.

Peso molecular

156,0500 g/mol

LogP

0,90

TPSA

3,20 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Mecanismo de acción

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(CCCl)CCCl

InChI

InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3

Molecular Formula

C5H11Cl2N

HBD / HBA

- / 1

Enlaces Rotables

4

Átomos Pesados

8

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A nitrogen mustard alkylating agent used as a chemotherapy treatment for certain blood cancers including Hodgkin lymphoma and mycosis fungoides, working by cross-linking DNA strands to prevent cancer cell replication. It is one of the oldest chemotherapy drugs still in use today.

Forms covalent bonds with DNA bases, creating cross-links and strand breaks that prevent DNA replication and transcription. This triggers apoptosis in rapidly dividing cells, particularly cancer cells.

Yes, Mechlorethamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL427. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4033. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.